Economic cost of visual impairment in Japan.

OBJECTIVE To quantify the total economic cost of visual impairment in Japan. METHODS A prevalence-based approach was adopted using data on visual impairment, the national health system, and indirect costs to capture the economic impact of visual impairment in 2007. RESULTS In 2007, visual impairment affected more than 1.64 million people in Japan and cost around yen 8785.4 billion (US $72.8 billion) across the economy, equivalent to 1.7% of Japan's gross domestic product. The loss of well-being (years of life lost from disability and premature mortality) cost yen 5863.6 billion (US $48.6 billion). Direct health system costs were yen 1338.2 billion (US $11.1 billion). Other financial costs were yen 1583.5 billion (US $13.1 billion), including productivity losses, care takers' costs, and efficiency losses from welfare payments and taxes. Community care was the largest component of other financial costs and was composed of paid and unpaid services that provide home and personal care to people with visual impairment. The findings of this study are in line with those of similar studies in Australia and the United States. CONCLUSIONS Visual impairment imposes substantial costs on society, particularly to individuals with visual impairment and their families. Eliminating or reducing disabilities from visual impairment through public awareness of preventive care, early diagnosis, more intensive disease treatment, and new medical technologies could significantly improve the quality of life for people with visual impairment and their families, while also potentially reducing national health care expenditure and increasing productivity in Japan. The results of this study should provide a first step in helping policymakers evaluate policy effects and to prioritize research expenditures.

[1]  R. Klein,et al.  The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.

[2]  H. Taylor,et al.  Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. , 1997, American journal of ophthalmology.

[3]  J. Schmier,et al.  MEDICARE EXPENDITURES ASSOCIATED WITH DIABETES AND DIABETIC RETINOPATHY , 2009, Retina.

[4]  Alastair Gray,et al.  Economic burden of cardiovascular diseases in the enlarged European Union. , 2006, European heart journal.

[5]  Y. Nose,et al.  Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study , 2004, Diabetologia.

[6]  Y. Kiyohara,et al.  Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study , 2001, The British journal of ophthalmology.

[7]  A. Iwase,et al.  The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. , 2004, Ophthalmology.

[8]  Charles E. Stuart Welfare Costs per Dollar of Additional Tax Revenue in the United States , 1984 .

[9]  N. Shimizu,et al.  Refractive errors and factors associated with myopia in an adult Japanese population. , 2003, Japanese journal of ophthalmology.

[10]  H. Taylor,et al.  Costs of interventions for visual impairment. , 2007, American journal of ophthalmology.

[11]  Alan R. Morse,et al.  Acute care hospital utilization by patients with visual impairment. , 1999, Archives of ophthalmology.

[12]  Emily W. Gower,et al.  Economic impact of visual impairment and blindness in the United States. , 2007, Archives of ophthalmology.

[13]  Y. Akanuma,et al.  Prevalence of chronic complications in Japanese diabetic patients. , 1994, Diabetes research and clinical practice.

[14]  J E Keeffe,et al.  The economic impact and cost of visual impairment in Australia , 2005, British Journal of Ophthalmology.

[15]  A. Iwase,et al.  Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. , 2006, Ophthalmology.

[16]  G. Berdeaux,et al.  Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries , 2012, PharmacoEconomics.

[17]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[18]  A. Iwase,et al.  The prevalence of primary open-angle glaucoma in Japanese*1The Tajimi Study , 2004 .

[19]  M. Kojima,et al.  [Cataract epidemiology survey in the three climatically different areas in Japan--prevalence of cataracts and types of lens opacification]. , 1995, Nippon Ganka Gakkai zasshi.

[20]  A. Tamakoshi,et al.  Report on the nationwide epidemiological survey of exudative age-related macular degeneration in Japan , 2004, International Ophthalmology.

[21]  H. Nomura,et al.  Visual Acuity in a Community-dwelling Japanese Population and Factors Associated with Visual Impairment , 2003, Japanese Journal of Ophthalmology.

[22]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[23]  A. Iwase,et al.  The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. , 2005, Ophthalmology.

[24]  H. Hirai,et al.  Prevalence of myopia and refractive changes in students from 3 to 17 years of age. , 1999, Survey of ophthalmology.